ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
ACCENDRA HEALTH INC/VA/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.22−0.01 (-6.30%)
Close on Oct 19, 2026
- Market cap
- $16.89M
- P/E (TTM)
- –
- Dividend yield
- –
Accendra Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Wholesale-Medical, Dental & Hospital Equipment & Supplies companies for comparison
Valuation
| Measure | Accendra Health | Industry median |
|---|---|---|
| Market Cap | $16.93M | $601.21M |
| Enterprise Value | $1.73B | $642.98M |
| PS Ratio | 0.01 | 0.90 |
Enterprise value
| Measure | Accendra Health | Industry median |
|---|---|---|
| EV / Sales | 0.65 | 0.99 |
| EV / EBITDA | 6.05 | 12.93 |
| EV / EBIT | 58.85 | 16.95 |
Income (trailing twelve months)
| Measure | Accendra Health | Industry median |
|---|---|---|
| Revenue | $2.65B | $1.44B |
| Gross Profit | $1.19B | $453.14M |
| Operating Income | $29.35M | $24.33M |
| Pretax Income | -$115.48M | $18.81M |
| Net Income | -$302.14M | $9.02M |
| EBITDA | $285.43M | $56.48M |
| EPS (Diluted) | -$3.92 | $0.66 |
Margins
| Measure | Accendra Health | Industry median |
|---|---|---|
| Gross Margin | 44.8% | 25.4% |
| Operating Margin | 1.11% | 3.37% |
| Pretax Margin | -4.36% | 3.72% |
| Profit Margin | -11.4% | 2.26% |
| EBITDA Margin | 10.8% | 5.04% |
| FCF Margin | -13.5% | 3.03% |
Returns
| Measure | Accendra Health | Industry median |
|---|---|---|
| Return on Assets (ROA) | -9.65% | 2.59% |
| Return on Invested Capital (ROIC) | 1.65% | 8.11% |
| Return on Capital Employed (ROCE) | 2.04% | 8.62% |
Growth
| Measure | Accendra Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -3.30% | 6.37% |
| Revenue Growth (3Y CAGR) | -34.8% | 1.68% |
| Revenue Growth (5Y CAGR) | -20.1% | 8.00% |
Balance sheet
| Measure | Accendra Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $7.65M | $36.92M |
| Total Debt | $1.72B | $297.09M |
| Net Cash (Debt) | -$1.71B | -$1.76M |
| Net Cash Per Share | -$22.24 | -$0.11 |
| Equity (Book Value) | -$550.94M | $230.41M |
| Book Value Per Share | -$7.16 | $15.79 |
| Tangible Book Value | -$1.86B | $39.91M |
| Working Capital | -$394.77M | $150.25M |
Financial position
| Measure | Accendra Health | Industry median |
|---|---|---|
| Current Ratio | 0.41 | 2.05 |
| Quick Ratio | 0.01 | 0.94 |
| Debt / EBITDA | 6.02 | 1.61 |
| Net Debt / EBITDA | 5.99 | 1.43 |
| Interest Coverage | 0.24 | 1.40 |
Cash flow (trailing twelve months)
| Measure | Accendra Health | Industry median |
|---|---|---|
| Operating Cash Flow | -$180.42M | $4.85M |
| Capital Expenditures | -$176.77M | -$20.25M |
| Free Cash Flow | -$357.19M | $51.20M |
| FCF Per Share | -$4.64 | $2.29 |
Efficiency
| Measure | Accendra Health | Industry median |
|---|---|---|
| Asset Turnover | 0.85 | 1.34 |
| Inventory Turnover | 20.49 | 4.85 |
| Revenue Per Employee | $407.27K | $719.81K |
| Profits Per Employee | -$46.48K | $10.61K |
| Employee Count | 6,500 | 787 |
Dividends and yields
| Measure | Accendra Health | Industry median |
|---|---|---|
| Earnings Yield | -1784.2% | 3.07% |
| FCF Yield | -2109.3% | 3.76% |
Shares
| Measure | Accendra Health | Industry median |
|---|---|---|
| Shares Outstanding | 76,904,700 | 38,108,300 |
| Shares Change (YoY) | -0.93% | 0.00% |
| Shares Change (QoQ) | 0.42% | 0.14% |
| Float | 60,743,400 | 34,810,650 |
| Shares Held by Insiders | 21.0% | 16.0% |
| Shares Held by Institutions | 81.1% | 82.3% |
Taxes
| Measure | Accendra Health | Industry median |
|---|---|---|
| Income Tax | -$4.89M | $15.10M |
Scores
| Measure | Accendra Health | Industry median |
|---|---|---|
| Altman Z-Score | 0.30 | 3.12 |
| Piotroski F-Score | 2 | 5 |
Calculated by StockData from Accendra Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.